Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2014 May 20:9:116.
doi: 10.1186/1748-717X-9-116.

Management of brain metastases with stereotactic radiosurgery alone versus whole brain irradiation alone versus both

Affiliations
Randomized Controlled Trial

Management of brain metastases with stereotactic radiosurgery alone versus whole brain irradiation alone versus both

Mahmoud M El Gantery et al. Radiat Oncol. .

Abstract

Introduction: This prospective randomized study aimed to evaluate the role of WBRT + SRS compared to SRS alone and to WBRT alone in improvement of overall survival, brain local control and neurologic manifestations.

Patients and methods: The trial included 60 patients with 1 to 3 brain metastases treated at the Radiotherapy Department, National Cancer Institute. 21 patients received WBRT + SRS, 18 patients received SRS alone and 21 patients received WBRT alone.

Results: Median local control was significantly better for WBRT + SRS compared to SRS alone & WBRT alone (10 vs 6 vs 5 months, respectively, P = 0.04). There was non significant survival benefit for WBRT + SRS compared to SRS alone & WBRT alone. Survival was significantly better for patients with controlled primary tumor who received WBRT + SRS compared to SRS alone & WBRT alone (median survival was 12 vs 5.5 vs 8 months, respectively. P = 0.027). Regardless of the treatment group, median survival and median local control were highly significantly better for single brain site involvement compared to multiple brain sites involvement (P = 0.003 & P = 0.001, respectively), and median brain local control was significantly better for single lesion compared to multiple lesions (P = 0.05).

Conclusions: WBRT + SRS is an effective, safe tool in treatment of patients with 1 to 3 brain metastses improving the brain local control, but further studies with larger number of patients is recommended.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Distribution of patients in studied arms according to no. of brain lesions.
Figure 2
Figure 2
Local control of the 3 treatments groups.
Figure 3
Figure 3
The LC according to number of brain lesions.
Figure 4
Figure 4
The LC according to number of brain sites involved.
Figure 5
Figure 5
Overall survival for all patients.
Figure 6
Figure 6
Overall survival for each treatment group.
Figure 7
Figure 7
Overall survival according to number of brain sites involved.

References

    1. Posner JB. Management of brain metastases. Rev Neurol (Paris) 1992;148(6–7):477–487. - PubMed
    1. Wen PY, Loeffler JS. Management of brain metastases. Oncology (Williston Park) 1999;13(7):941–954. 957–962, 969. - PubMed
    1. Loeffler JS, Patchell RA, Sawaya R. In: Cancer: Principles and Practice of Oncology. 5. Devita VT, Hellman S, Rosenberg SA, editor. Philadelphia: Lippincott-Raven; 1997. Treatment of metastatic cancer; pp. 2523–2525.
    1. Eichler AF, Loeffler JS. Multidisciplinary management of brain metastases. Onccologist. 2007;12(7):884–898. doi: 10.1634/theoncologist.12-7-884. - DOI - PubMed
    1. Aoyama H, Shirato H, Tago M, Nakagawa K, Toyoda T, Hatano K, Kenjyo M, Oya N, Hirota S, Shioura H, Kunieda E, Inomata T, Hayakawa K, Katoh N, Kobashi G. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA. 2006;295(21):2483–2491. doi: 10.1001/jama.295.21.2483. - DOI - PubMed

Publication types